Chemical Structure : BR-cpd7
货号: PC-22214Not For Human Use, Lab Use Only.
BR-cpd7 is a potent, selective FGFR1/2-targeting proteolysis targeting chimeric (PROTAC) degrader with DC50 of 10 nM, while sparing FGFR3.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BR-cpd7 is a potent, selective FGFR1/2-targeting proteolysis targeting chimeric (PROTAC) degrader with DC50 of 10 nM, while sparing FGFR3.
BR-cpd7 induces cell cycle arrest and consequently blocks the proliferation of multiple FGFR1/2-dependent tumor cells.
BR-cpd7 shows no anti-proliferative activity against cancer cells without FGFR aberrations.
BR-cpd7 exhibits robust antitumor effects in FGFR1-dependent lung cancer at well-tolerated dose schedules, accompanied by complete FGFR1 depletion in vivo.
分子量 | ||
分子式 | ||
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Ying Kong, et al. Mol Cancer Ther. 2024 Apr 22. doi: 10.1158/1535-7163.MCT-23-0719.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright